RADNOR, Pa., March 02, 2021 (GLOBE NEWSWIRE) The law firm of Kessler Topaz Meltzer & Check, LLP reminds iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against iRhythm on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive (the “Class Period”). Lead Plaintiff Deadline: April 2, 2021 Website:https://www.ktmc.com/irhythm-technologies-inc-securities-class-action?utm source=PR&utm medium=link&utm campaign=irhythm Contact:James Maro, Esq. (484) 270-1453 Adrienne Bell, Esq. (484) 270-1435 Toll free (844) 887-9500 According to the complaint, iRhythm is a digital healthcare company that offers a portfolio of ambulatory cardiac monitoring services on its platform called the Zio service. iRhythm receives revenue for its Zio service prima
LOS ANGELES, March 03, 2021 (GLOBE NEWSWIRE) Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 2, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) common stock between August 4, 2020 and January 28, 2021, inclusive (the “Class Period”). If you suffered a loss on your iRhythm investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/irhythm-technologies-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights. On December 1, 2020, the Centers for Medicare and Medicaid Services (“CMS
RADNOR, PA / ACCESSWIRE / March 1, 2021 / The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against iRhythm Technologies, Inc. (NASDAQ:IRTC) ("iRhythm") on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive (the "Class Period").
NEW YORK, NY / ACCESSWIRE / March 1, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court.
BOSTON, March 01, 2021 (GLOBE NEWSWIRE) Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that it has filed a class action lawsuit on behalf of shareholders against iRhythm Technologies, Inc. (NASDAQ: IRTC) and one of its former executives for securities fraud. Investors who purchased IRTC shares between August 4, 2020 and January 28, 2021 and who lost money are strongly encouraged to contact Block & Leviton attorneys at (617) 398-5600, via email at cases@blockleviton.com, or visit our website for information on the case. The deadline to move the Court for appointment as lead plaintiff is April 2, 2021. iRhythm Technologies provides wearable biosensor devices to detect and monitor heart arrythmias. On December 2, 2020, iRhythm issued a press release stating that new Centers for Medicare and Medicaid Services (CMS) physician fee guidelines would change how payments for its Zio XT remote cardiac monitoring services would be c